The National Institute for Health and Care Excellence (NICE) clinical guideline on cardiovascular disease: risk assessment and reduction, including lipid modification provides evidence-based guidance for healthcare professionals on lipid measurement. Healthcare professionals are expected to take NICE guidelines fully into account in the care and treatment of individual patients.

To tackle unwarranted variation and support consistent, high-quality care across the cardiovascular pathway, the Government will publish a new Cardiovascular Disease Modern Service Framework (CVD MSF) later this year.

As part of this, the CVD MSF will identify the best-evidenced interventions and set clear standards on how they should be used, alongside a clear strategy to support and oversee uptake by clinicians and providers. This approach will help ensure greater consistency in the detection, assessment, and management of cardiovascular risk factors, such as cholesterol.